The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2023

Filed:

Sep. 27, 2022
Applicant:

B. J. Zh. F. Panther Medical Equipment Co., Ltd., Beijing, CN;

Inventor:

Qing Liu, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/36 (2006.01); A61L 24/00 (2006.01); A61L 15/44 (2006.01); A61L 15/20 (2006.01); A61L 27/54 (2006.01); A61L 27/52 (2006.01); A61K 33/38 (2006.01); A61L 15/40 (2006.01); A61L 27/02 (2006.01);
U.S. Cl.
CPC ...
A61L 27/3629 (2013.01); A61K 33/38 (2013.01); A61L 15/20 (2013.01); A61L 15/40 (2013.01); A61L 15/44 (2013.01); A61L 24/0005 (2013.01); A61L 24/0015 (2013.01); A61L 27/02 (2013.01); A61L 27/3687 (2013.01); A61L 27/3691 (2013.01); A61L 27/54 (2013.01); A61L 2300/104 (2013.01); A61L 2300/216 (2013.01); A61L 2300/404 (2013.01); A61L 2430/34 (2013.01);
Abstract

An antibacterial medical biomaterial includes an acellular small intestinal submucosal matrix material, an antibacterial gel layer located on a surface of the acellular small intestinal submucosal matrix material, and an absorbable fiber layer located on a surface of the antibacterial gel layer. Sulfadiazine silver is on the surface of the acellular small intestinal submucosal matrix material and/or within the acellular small intestinal submucosal matrix material. An absorbable fiber layer to which the sulfadiazine silver is attached, wherein the content of sulfadiazine silver in the absorbable fiber is 1 wt. %˜2 wt. %. The medical biomaterial is usable as an external medicine for treating wound infections relayed by burns or wounds, and for reducing the incidence of infection by using a conventional central venous catheter with a sulfadiazine silver antibacterial coating, so that the medical biomaterial loaded with sulfadiazine silver also has antibacterial activity consistent with sulfadiazine silver.


Find Patent Forward Citations

Loading…